atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference.
Details of the company’s participation is as follows:
2023 Cantor Fitzgerald Global Healthcare Conference
Format: Fireside Chat
Date and Time: Thursday, September 28th at 1:50 P.M. ET
Location: New York, NY
A webcast of the company’s fireside chat will be available on atai’s website under Events on the Invesors section of the atai website: https://ir.atai.life/news-events/events/. A replay will be available following the live event.
About atai Life Sciences
By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients.
atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.
Keynote Presentation by Genesys
Making the Transition from MSP to MSSP
Solutions Showcase Session